Bioengineering MSCs for untapped therapeutic potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bioengineering MSCs for untapped therapeutic potential

Published:2024-09-13 Issue: Volume: Page:1-5
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Sirpilla Olivia¹²³⁴^ORCID,Kenderian Saad S¹²⁵⁶^ORCID

Affiliation:

1. T Cell Engineering, Mayo Clinic, Rochester, MN 55905, USA

2. Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA

3. Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA

4. Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA

5. Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA

6. Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA

Funder

NIHMS

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1750743X.2024.2390819

Reference26 articles.

1. Immunobiology of mesenchymal stem cells

2. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy

3. Shattering barriers toward clinically meaningful MSC therapies

4. A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

5. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP